CHICAGO (GenomeWeb) — Seegene this week plans to submit its first molecular diagnostic test for US Food and Drug Administration clearance, an assay for herpes simplex virus I and II that uses the company's TOCE primer technology for multiplexed real-time PCR.
NEW YORK (GenomeWeb News) – Seegene said today that BioMérieux has taken a license to its DPO and TOCE technologies for the development of multiplexed molecular tests for food safety.
Financial terms of the agreement were not disclosed.
Molecular diagnostics and assay technology developer Seegene said this week that it has added yet another multiplex PCR-based chemistry to its portfolio of nucleic acid amplification, detection, and quantification technologies.
Seegene and DuPont Nutrition & Health said today that they have inked an agreement to jointly develop highly multiplexed assays to detect foodborne pathogens by combining Seegene's real-time PCR and melt curve analysis technology with DuPont's benchtop BAX System.
Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.